Frazier Life Sciences Management, L.P.

Holdings History for Replimune Group, Inc. - Common Stock, par value $0.001 per share (REPL)

Symbol: REPL on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2023		-0.44%	$0	0	-386,762	-100%	$7.78	Q4 2023
30 Sep 2023	0.44%	0%	$6,617,498	386,762	0		$17.11	Q3 2023
30 Jun 2023	0.54%	-0.42%	$8,980,614	386,762	-300,000	-44%	$23.22	Q2 2023
31 Mar 2023	0.88%	-0.31%	$12,128,217	686,762	-244,798	-26%	$17.66	Q1 2023
31 Dec 2022	1.6%	+0.21%	$25,338,432	931,560	+125,293	+16%	$27.20	Q4 2022
30 Sep 2022	1.1%	0%	$13,924,000	806,267	0		$17.27	Q3 2022
30 Jun 2022	1.4%	+0.15%	$14,094,000	806,267	+89,505	+12%	$17.48	Q2 2022
31 Mar 2022	1%	0%	$12,171,000	716,762	0		$16.98	Q1 2022

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.